Markt oder Branche auswählen:
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines | 742 | PR Newswire | WASHINGTON, April 9, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today highlighted a legislative proposal contained in the FDA's FY 2027... ► Artikel lesen | |
| Do | Kymera Therapeutics, Inc.: Kymera Therapeutics Announces Gilead Sciences' Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate | 410 | GlobeNewswire (Europe) | KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead Sciences WATERTOWN, Mass.... ► Artikel lesen | |
| Do | Tempus AI Expands Collaboration With Gilead Sciences To Maximize Insights In Oncology Pipeline | 314 | AFX News | FOSTER CITY (dpa-AFX) - Healthcare technology company Tempus AI, Inc. (TEM) Thursday announced an expanded, multi-year collaboration with Gilead Sciences, Inc. (GILD) to build and advance its... ► Artikel lesen | |
| Do | Zymeworks Inc.: Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth | 308 | GlobeNewswire (Europe) | • Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq:... ► Artikel lesen | |
| Do | C4 Therapeutics Enters Collaboration Agreement With Roche | 286 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - C4 Therapeutics (CCCC) has entered into a new collaboration agreement with Roche (RHHBY, RO.SW, ROG.SW) to advance research in the degrader-antibody conjugate... ► Artikel lesen | |
| Do | Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles | 116 | GlobeNewswire (Europe) | Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can already provide sufficient statistical power to support... ► Artikel lesen | |
| Do | Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy | 113 | GlobeNewswire (Europe) | SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| AMGEN | 303,30 | 8,25 | +2,72 % | 2,52 | 15.05.2026 | |
| ROYALTY PHARMA | 40,730 | 0,76 | +1,87 % | 0,24 | 20.02.2026 | |
| REGENERON PHARMACEUTICALS | 653,60 | 3,02 | +0,46 % | 0,94 | 20.02.2026 | |
| IONIS PHARMACEUTICALS | 65,76 | 0,00 | 0,00 % | |||
| BIOGEN | 152,12 | 0,00 | 0,00 % | |||
| VERA THERAPEUTICS | 40,940 | 0,00 | 0,00 % | |||
| LENZ THERAPEUTICS | 9,310 | 0,00 | 0,00 % |
| Aktien WKN | Akt. Kurs Vortag | +/- % | Zeit | ||
|---|---|---|---|---|---|
| 10X GENOMICS INC A2PPQJ Tradegate | 19,362 19,666 | -0,304 -1,55 % | 08:03 | ||
| 4D MOLECULAR THERAPEUTICS INC A2PS5P NASDAQ | 9,840 10,080 | -0,240 -2,38 % | 09.04. | ||
| AARDVARK THERAPEUTICS INC A412BL NASDAQ | 3,900 3,945 | 0,000 0,00 % | 09.04. | ||
| ABCELLERA BIOLOGICS INC A2QKXS Tradegate | 2,985 2,935 | +0,050 +1,70 % | 10:06 | ||
| ABIVAX SA ADR A3EWCP Tradegate | 109,000 107,00 | +2,00 +1,87 % | 10:26 | ||
| ABSCI CORPORATION A3CVW3 NASDAQ | 2,960 2,985 | 0,000 0,00 % | 09.04. | ||
| AC IMMUNE SA A2AR5F Tradegate | 2,840 2,905 | -0,065 -2,24 % | 11:42 | ||
| ACADIA PHARMACEUTICALS INC 603035 Stuttgart | 19,085 19,245 | -0,160 -0,83 % | 11:31 | ||
| ACLARIS THERAPEUTICS INC A1412H Tradegate | 3,452 3,492 | -0,040 -1,15 % | 07:31 | ||
| ADAPTIVE BIOTECHNOLOGIES CORPORATION A2PLR5 Stuttgart | 11,405 11,395 | +0,010 +0,09 % | 11:03 |
03.04.
BASEL (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., EU, and China, acquisitions, a few key trial goal misses and positive clinical trial data readouts across therapeutic areas like Psoriasis, Asthma...
► Artikel lesen
► Artikel lesen
Di
Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ARCA CONTINENTAL SAB DE CV MX01AC100006 4,28 MXN 0,2085 EUR BANK OF NOVA SCOTIA CA0641491075 1,1 CAD 0,6851 EUR CAIXABANK SA ES0140609019 - 0,3321 EUR COUSINS PROPERTIES INC US2227955026 0...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
- CAIXABANK SA
- BANK OF NOVA SCOTIA
- ERIE INDEMNITY COMPANY
- EDISON INTERNATIONAL
- UPBOUND GROUP INC
- GLACIER BANCORP INC
- DOLLAR GENERAL CORPORATION
- SYLVAMO CORPORATION
- COUSINS PROPERTIES INC
- ARCA CONTINENTAL SAB DE CV
- MATCH GROUP INC
- SIGA TECHNOLOGIES INC
- HUBER+SUHNER AG
- PSP SWISS PROPERTY AG
- JOHN WILEY & SONS INC
- PREFERRED BANK
- SIGNAUX GIROD SA
- FIRST BANCORP INC
- SHINE JUSTICE LTD
- SMITHFIELD FOODS INC
29.03.
BioNTech treibt den strategischen Wandel hin zu einem Onkologie-Unternehmen voran und erzielt dabei erste vielversprechende klinische Fortschritte, insbesondere im Bereich Lungenkrebs. Gleichzeitig belasten schwache Finanzzahlen, sinkende Covid-19-Einnahmen...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
28.03.
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed either Q4W or Q12W, showed progressively increasing...
► Artikel lesen
► Artikel lesen
Aktien im Artikel:
27.03.
NEW YORK (dpa-AFX) - Die US-Aktienmärkte haben am Freitag ihre Talfahrt fortgesetzt. Der anhaltende Iran-Krieg und die weiter steigenden Ölpreise mahnen die Anleger zur Vorsicht. Auf die Stimmung drückte auch Chinas Entscheidung, vor dem erwarteten...
► Artikel lesen
► Artikel lesen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.